LOP12

    Niclas Broer, Katie E. Weichman, Marc E. Walker, C. Goldberg, Samuel Buonocore, Demetrios T. Braddock, Rossitza Lazova, Deepak Narayan, Stephan Ariyan
    Image of study
    TLDR Sentinel lymph node biopsy is recommended for all types of desmoplastic melanoma due to higher rates of nodal metastasis.
    The document presents the findings of a study on desmoplastic melanoma (DM) and the incidence of nodal metastasis, with a focus on the utility of sentinel lymph node biopsy (SLNB) in this melanoma subtype. Over a twelve-year period (1998-2010), 24 patients (0.7% of 3531 melanoma cases) with DM were identified at the Yale Melanoma Unit. Of these, 22 underwent SLNB, and 4 (18%) were found to have micro-metastasis. Following completion lymphadenectomy, no additional positive nodes were found. Over a median follow-up of 25 months, 2 patients (9%) had local recurrence, 2 (9%) had in-transit recurrence, and 6 (27%) developed distant metastases. The study found higher rates of nodal metastasis in both pure DM (14%) and mixed DM (25%) subtypes compared to previously reported rates. Consequently, the authors recommend SLNB for patients with both pure and mixed DM subtypes.
    Discuss this study in the Community →